CliffBio
small molecule

SYMPROIC

NALDEMEDINE TOSYLATE

Loss of exclusivityMay 2033latest FDA-listed patent expiry
CompanyBioDelivery Sciences International →View the full company profile on CliffBio

Drug detail

Brand nameSYMPROIC
Active ingredientNALDEMEDINE TOSYLATE
StrengthEQ 0.2MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2017
Marketing statusRX

Listed patents

PatentExpiresType
10952968May 2033substance, product
12350377May 2033product
9108975November 2031substance, product
RE46365February 2031substance, product
RE46375October 2026substance, product

More from BioDelivery Sciences International

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found